Neuro RX Gamma for Amnestic Mild Cognitive Impairment (aMCI)

Clinical trial NCT05563298 · COMPLETED

Trial details

NCT number: NCT05563298
Sponsor: Unity Health Toronto
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

MCI Amnestic Mild Cognitive Disorder

Start date: 2023-03-28
Primary completion: 2025-02-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.